Expression of hepatitis B surface antigen in tobacco cell suspension cultures.

Hepatitis B virus ' s ' gene coding for surface antigen was cloned into plant transformation vectors pHER100 and pHBs100 with and without endoplasmic reticulum retention signal, respectively. Transformed tobacco cell lines were analyzed for the integration of the transgene by PCR and Southern blot hybridization. Expression levels as determined by ELISA showed maximum expression levels of 2 microg HBsAg gm(-1) fresh weight and 10 ng mL(-1) of spent medium in pHER100 transformed cells. Western blot analysis confirmed the presence of 24 kDa band specific to HBsAg in the transformed cells. HBsAg was expressed both as intracellular and secreted forms in pHER100 transformed cells. The buoyant density in CsCl of HBsAg derived from pHBs100 transformed tobacco cells was determined and found to be 1.095 g mL(-1). HBsAg obtained from transformed tobacco cells is similar to the human serum derived one in buoyant density properties. This is the first report on the secretion of HBsAg particles by plant cells into the cell culture medium.

[1]  A. Hiatt,et al.  Protein production in transgenic crops: analysis of plant molecular farming. , 1993 .

[2]  F. Skoog,et al.  A revised medium for rapid growth and bio assays with tobacco tissue cultures , 1962 .

[3]  U. Conrad,et al.  Optimization of scFv antibody production in transgenic plants. , 1997, Immunotechnology : an international journal of immunological engineering.

[4]  M. Figlerowicz,et al.  A plant‐derived edible vaccine against hepatitis B virus , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  T. Ganapathi,et al.  MSI-99, a magainin analogue, imparts enhanced disease resistance in transgenic tobacco and banana , 2003, Planta.

[6]  W. Stiekema,et al.  The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco , 1996, Plant Molecular Biology.

[7]  M. Van Montagu,et al.  Bacterial and plant‐produced scFv proteins have similar antigen‐binding properties , 1996, FEBS letters.

[8]  C. Arntzen,et al.  Production of hepatitis B surface antigen in transgenic plants for oral immunization , 2000, Nature Biotechnology.

[9]  C. Arntzen,et al.  Oral immunization with hepatitis B surface antigen expressed in transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Kozak.  Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. , 1981, Nucleic acids research.

[11]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[12]  C. Arntzen,et al.  Transgenic plants as vaccine production systems. , 1995, Trends in biotechnology.

[13]  U. Conrad,et al.  Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity , 1998, Plant Molecular Biology.

[14]  U. Conrad,et al.  Expression of engineered antibodies in plant cells , 1994, Plant Molecular Biology.

[15]  B D Hall,et al.  Synthesis and assembly of hepatitis B virus surface antigen particles in yeast , 1982, Nature.

[16]  A. Kumar,et al.  Immunoprophylaxis of hepatitis B virus infection. , 2001, Indian journal of medical microbiology.

[17]  D. M. Lam,et al.  Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. Raskin,et al.  Production of recombinant proteins in plant root exudates , 1999, Nature Biotechnology.

[19]  R. Reeves,et al.  Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. , 2000, Protein expression and purification.

[20]  I. Raskin,et al.  Production of recombinant proteins in tobacco guttation fluid. , 2000, Plant physiology.

[21]  R. Reeves,et al.  Combined use of regulatory elements within the cDNA to increase the production of a soluble mouse single-chain antibody, scFv, from tobacco cell suspension cultures. , 2002, Protein expression and purification.

[22]  N. Emans,et al.  Towards molecular farming in the future: using plant‐cell‐suspension cultures as bioreactors , 1999, Biotechnology and applied biochemistry.

[23]  A. Hiatt.  Transgenic plants: fundamentals and applications. , 1993 .

[24]  Shinya Matsumoto,et al.  Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells , 1995, Plant Molecular Biology.

[25]  A. Depicker,et al.  Plants as bioreactors for protein production: avoiding the problem of transgene silencing , 2004, Plant Molecular Biology.

[26]  J. Draper,et al.  Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures , 1993, Plant Molecular Biology.

[27]  P. Lyons,et al.  Immunogenicity of transgenic plant-derived hepatitis B surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Elizabeth E. Hood,et al.  NewAgrobacterium helper plasmids for gene transfer to plants , 1993, Transgenic Research.

[29]  M. Bevan,et al.  Endoplasmic reticulum targeting and glycosylation of hybrid proteins in transgenic tobacco. , 1989, The Plant cell.

[30]  G. Vyas,et al.  Biology of hepatitis B virus. , 1981, Science.

[31]  C. N. Stewart,et al.  A rapid CTAB DNA isolation technique useful for RAPD fingerprinting and other PCR applications. , 1993, BioTechniques.